Trial Profile
Short Treatment with the Angiotensin Receptor Blocker Candesartan Surveyed by Telemedicine [STAR-CAST]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2013
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Nifedipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms STAR CAST; STAR-CAST
- 30 Jun 2013 Status changed from recruiting to completed.
- 17 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
- 21 Jul 2010 A total of 187 patients have been enrolled in the study so far, according to an abstract presented at the 20th European Meeting on Hypertension.